High-density lipoprotein and residual cardiovascular risk: De minimis non curat medicus or the COURAGE to be SMART?

Affiliations

Free article

Editorial

Jacques Genest. J Am Coll Cardiol. 2013.

Free article

. 2013 Nov 12;62(20):1842-4.

doi: 10.1016/j.jacc.2013.05.087. Epub 2013 Aug 21.

¹ McGill University Health Center/Royal Victoria Hospital, Montreal, Quebec, Canada. Electronic address: jacques.genest@mcgill.ca.

No abstract available

Keywords: HDL cholesterol; LDL cholesterol; secondary prevention; statins.

Comment on

Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.
van de Woestijne AP, van der Graaf Y, Liem AH, Cramer MJ, Westerink J, Visseren FL; SMART Study Group. van de Woestijne AP, et al. J Am Coll Cardiol. 2013 Nov 12;62(20):1834-41. doi: 10.1016/j.jacc.2013.04.101. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23948286
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ, Sedlis SP, Kostuk W, Spertus JA, Dada M, Chaitman BR, Mancini GB, Weintraub WS. Acharjee S, et al. J Am Coll Cardiol. 2013 Nov 12;62(20):1826-33. doi: 10.1016/j.jacc.2013.07.051. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23973693 Free PMC article.